TeleTrader 11-20 Valo Health partners with Merck in $3 billion deal
GlobeNewswire 11-19 Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
GlobeNewswire 11-19 SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
GlobeNewswire 11-17 Adcytherix Powers Ahead: Technology and Team in Place to Deliver Strategy and Build an ADC Powerhous...
GlobeNewswire 11-14 $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cidara Therapeutics, Inc....
GlobeNewswire 11-14 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cidara Ther...
GlobeNewswire 11-14 IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
TeleTrader 11-14 Merck to buy Cidara for about $9.2B
GlobeNewswire 11-14 Mersana Therapeutics Provides Business Update and Announces Third Quarter 2025 Financial Results
GlobeNewswire 11-13 Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted ...
GlobeNewswire 11-13 PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
TeleTrader 11-11 Dow up 550 pts at close, govt shutdown end in sight
GlobeNewswire 11-11 Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
GlobeNewswire 11-10 Codexis Announces Signing of Lease for GMP Manufacturing Facility
GlobeNewswire 11-10 PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of...
GlobeNewswire 11-10 Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial ...
GlobeNewswire 11-10 HCW Biologics Shares the Latest Data for its Second-Generation Immune Checkpoint Inhibitor Presented...
GlobeNewswire 11-10 Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board o...
GlobeNewswire 11-10 Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
GlobeNewswire 11-07 Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX...
GlobeNewswire 11-07 Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study a...
GlobeNewswire 11-06 Codexis Reports Third Quarter 2025 Financial Results
GlobeNewswire 11-06 CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 11-06 Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates
GlobeNewswire 11-06 Evaxion announces business update and third quarter 2025 financial results